Titre (en)
Analysis
an2020
Racine
Analysis
an2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Covid (26 mars) - Analysis (an2020)

Index « Titre (en) » - entrée « therapeutic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
themselves < therapeutic < therapeutics  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000095 (2020) L. Yang [République populaire de Chine] ; H Y Xu [République populaire de Chine] ; Y. Wang [République populaire de Chine][Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19)].
000136 (2020) J. Wang [République populaire de Chine] ; B J Wang [République populaire de Chine] ; J C Yang [République populaire de Chine] ; M Y Wang [République populaire de Chine] ; C. Chen [République populaire de Chine] ; G X Luo [République populaire de Chine] ; W F He [République populaire de Chine][Advances in the research of mechanism of pulmonary fibrosis induced by Corona Virus Disease 2019 and the corresponding therapeutic measures].
000220 (2020) Robert L. Kruse [États-Unis]Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000221 (2020) Phulen Sarma ; Manisha Prajapat ; Pramod Avti ; Hardeep Kaur ; Subodh Kumar ; Bikash MedhiTherapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
000222 (2020) Guangdi Li ; Erik De ClercqTherapeutic options for the 2019 novel coronavirus (2019-nCoV).
000266 (2020) Suliman Khan [République populaire de Chine] ; Rabeea Siddique [République populaire de Chine] ; Muhammad Adnan Shereen [République populaire de Chine] ; Ashaq Ali [République populaire de Chine] ; Jianbo Liu ; Qian Bai [République populaire de Chine] ; Nadia Bashir [République populaire de Chine] ; Mengzhou Xue [République populaire de Chine]The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options.
000401 (2020) Jaffar A. Al-Tawfiq [États-Unis] ; Ali H. Al-Homoud [Arabie saoudite] ; Ziad A. Memish [États-Unis]Remdesivir as a possible therapeutic option for the COVID-19.
000490 (2020) Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
000506 (2020) Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000979 (2020) Miguel Angel Martinez [Espagne]Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
000A18 (2020) Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine]Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
000B20 (2020) Kam Wa Chan [Hong Kong] ; Vivian Taam Wong [Hong Kong] ; Sydney Chi Wai Tang [Hong Kong]COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.
000B78 (2020) Didier Raoult [France] ; Po-Ren Hsueh [Taïwan] ; Stefania Stefani [Italie] ; Jean-Marc Rolain [France]COVID-19 Therapeutic and Prevention.
000B94 (2020) Jimin Xu ; Pei-Yong Shi ; Hongmin Li [États-Unis] ; Jia ZhouBroad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
000C27 (2020) Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine]Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
000C37 (2020) Shibo Jiang [République populaire de Chine] ; Lanying Du [États-Unis] ; Zhengli Shi [République populaire de Chine]An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/Title.i -k "therapeutic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/Title.i  \
                -Sk "therapeutic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    an2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    therapeutic
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021